OTCMKTS:BIEI Premier Biomedical (BIEI) Stock Price, News & Analysis $0.0009 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.0008▼$0.000950-Day Range N/A52-Week Range$0.0005▼$0.0017Volume1.52 million shsAverage Volume2.37 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get Premier Biomedical alerts: Email Address Ad True Market InsidersThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 About Premier Biomedical Stock (OTCMKTS:BIEI)Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.Read More BIEI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIEI Stock News HeadlinesJuly 23, 2024 | globenewswire.comPremier Graphene Targets Graphene-Enhanced Asphalt as a Potential Market Larger than CementJuly 8, 2024 | globenewswire.comPremier Graphene, Inc. Ships Advanced Graphene Suspension Samples to Global Leader in Essential MaterialsJuly 27, 2024 | Crypto 101 Media (Ad)Next opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…May 13, 2024 | globenewswire.comPremier Graphene, Inc., formerly Premier Biomedical Inc. (OTC: BIEI), announces major news in Mexico with our friends at HGI Industrial Technologies S.A de P.I and an advancement in its Graphene Enhanced ConcreteApril 17, 2024 | finance.yahoo.comPremier Graphene, Inc. (BIEI) Demonstrates Industry-Leading Innovations with Graphene-Enhanced Building MaterialsApril 17, 2024 | globenewswire.comPremier Graphene, Inc. (BIEI) Demonstrates Industry-Leading Innovations with Graphene-Enhanced Building MaterialsMarch 7, 2024 | globenewswire.comPremier Biomedical Inc. (BIEI), now known as Premier Graphene, Inc., engages Gustavo Carreño as Chief Technology Officer (CTO)February 13, 2024 | businessinsider.comSouthwest Premier Card Review 2024July 27, 2024 | Crypto 101 Media (Ad)Next opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…September 13, 2023 | benzinga.comSANGUINE BIOSCIENCES OPENS NEW APHERESIS DONOR CENTER TO SUPPORT CELL & GENE THERAPY AND TRANSLATIONAL RESEARCH INITIATIVESAugust 25, 2023 | seekingalpha.comBIEI Premier Biomedical, Inc.July 24, 2023 | bbc.co.ukPremier League pre-season fixtures: Where is your club playing this summer?July 23, 2023 | dailymail.co.ukPremier League transfer window: Your comprehensive club-by-club list of all the summer moves in 2023June 7, 2023 | usatoday.comIHG Rewards Premier Credit Card: Elite status at a budget priceMarch 30, 2023 | finance.yahoo.comPremier Biomedical Inc. (OTC: BIEI), Welcomes Officers, Directors and Key AdvisorsMarch 16, 2023 | finance.yahoo.comPremier Biomedical Inc. (OTC: BIEI), now known as Premier Graphene, Inc., collaborates with Oklahoma Based “Biographene Technology Inc”, for its Graphene ProductionFebruary 28, 2023 | finance.yahoo.comPremier Biomedical Inc. (OTC: BIEI), now known as Premier Graphene, Inc., specifies plans and timing for development of its Full Scale, Seed To Product Delivery, Graphene InitiativeFebruary 1, 2023 | finance.yahoo.comNova Graphene Ballistics (OTC PINK: BIEI) Retains Award Winning Communication Firm To Expand Public MessagingSee More Headlines Receive BIEI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:BIEI CUSIPN/A CIK1515740 Webwww.premierbiomedical.com Phone724-633-7033FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. David CaplanPresident, Chairman of the Board of Directors, Secretary & TreasurerMr. Gustavo CarreñoChief Technology OfficerMr. Carl EllerMarketing & Planning Vice-PresidentKey Competitors4Front VenturesOTCMKTS:FFNTFAbattis BioceuticalsOTCMKTS:ATTBFAesther Healthcare AcquisitionNASDAQ:AEHAWAgentixOTCMKTS:AGTXAlgernon PharmaceuticalsOTCMKTS:AGNPFView All Competitors BIEI Stock Analysis - Frequently Asked Questions How have BIEI shares performed this year? Premier Biomedical's stock was trading at $0.0009 at the start of the year. Since then, BIEI stock has decreased by 5.6% and is now trading at $0.0009. View the best growth stocks for 2024 here. How do I buy shares of Premier Biomedical? Shares of BIEI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Premier Biomedical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Premier Biomedical investors own include Co-Diagnostics (CODX), Allena Pharmaceuticals (ALNA), CytoDyn (CYDY), Inovio Pharmaceuticals (INO), Sierra Oncology (SRRA), Vaxart (VXRT) and MEI Pharma (MEIP). This page (OTCMKTS:BIEI) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Premier Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Premier Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
